British Patient Capital's investment focus is on providing long-term, patient capital to innovative UK companies, particularly those in the venture growth stage, to help them scale up. Their strategy involves investing in UK venture capital funds and directly co-investing alongside fund managers, with a particular interest in sectors such as sustainability, life sciences, and deep tech, all while operating on a commercial basis to achieve competitive returns.
Portfolio
1
Fund Size
$3.2B
Top Stage
Series A
Last 12 Mo
1
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
| Maxion Therapeutics | Series A | $72M | Mar 2025 |
Top Co-Investors
General Catalyst1 shared
BGF1 shared
Last updated: 27 February 2026